Insulin aspart, recombinant Subcutaneous and Zidovudine Capsules and Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Zidovudine Capsules and Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: zidovudine
Brand name: Retrovir
Synonyms: Zidovudine (oral/injection), Zidovudine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Zidovudine Injection
- Insulin aspart, recombinant Subcutaneous-Zidovudine Intravenous
- Insulin aspart, recombinant Subcutaneous-Zidovudine Oral Solution
- Insulin aspart, recombinant Subcutaneous-Zidovudine oral/injection
- Insulin aspart, recombinant Subcutaneous-Zidovudine Syrup
- Insulin aspart, recombinant Subcutaneous-Zidovudine Tablets
- Zidovudine Capsules and Tablets-Insulin degludec
- Zidovudine Capsules and Tablets-Insulin Degludec (U-100) Prefilled Pens
- Zidovudine Capsules and Tablets-Insulin Degludec (U-100) Vials
- Zidovudine Capsules and Tablets-Insulin Degludec (U-200) Prefilled Pens
- Zidovudine Capsules and Tablets-Insulin degludec and liraglutide
- Zidovudine Capsules and Tablets-Insulin degludec and liraglutide Subcutaneous